- call +1-201-465-4211
- email sales@mrinsights.biz
Molecular testing provides fast and accurate results and the prescence of molecular tests has disrupted several testing markets over the past decade and a half. However, some segments have thrived and others are seeing mature growth levels.
Scope of the Report:
This report details the highest revenue growth areas of molecular testing, as considered by manufacturers of IVD instruments, reagents and supplies. The report covers both high-growth product segments and regional markets of significance.
The global Molecular Blood market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Molecular Blood.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
This report studies the Molecular Blood market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Molecular Blood market by product type and applications/end industries.
Market Segment by Companies, this report covers
Abbott Laboratories
QIAGEN
Roche Diagnostics
Hologic
Grifols
Siemens Healthcare
Becton, Dickinson
Danaher
Biomerieux
Cepheid
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
PCR
PCR-RFLP
AS-PCR or PCR-SSP
Multiplex PCR
Real Time PCR
Sanger DNA Sequencing
Pyrosequencing
Market Segment by Applications, can be divided into
Blood Centers
Plasma Fractionation Facilities
Hospitals
Commercial/Private Laboratories
Military Blood Banks
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Molecular Blood Market Overview
1.1 Product Overview and Scope of Molecular Blood
1.2 Classification of Molecular Blood by Types
1.2.1 Global Molecular Blood Revenue Comparison by Types (2017-2023)
1.2.2 Global Molecular Blood Revenue Market Share by Types in 2017
1.2.3 PCR
1.2.4 PCR-RFLP
1.2.5 AS-PCR or PCR-SSP
1.2.6 Multiplex PCR
1.2.7 Real Time PCR
1.2.8 Sanger DNA Sequencing
1.2.9 Pyrosequencing
1.3 Global Molecular Blood Market by Application
1.3.1 Global Molecular Blood Market Size and Market Share Comparison by Applications (2013-2023)
1.3.2 Blood Centers
1.3.3 Plasma Fractionation Facilities
1.3.4 Hospitals
1.3.5 Commercial/Private Laboratories
1.3.6 Military Blood Banks
1.4 Global Molecular Blood Market by Regions
1.4.1 Global Molecular Blood Market Size (Million USD) Comparison by Regions (2013-2023)
1.4.1 North America (USA, Canada and Mexico) Molecular Blood Status and Prospect (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Molecular Blood Status and Prospect (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Molecular Blood Status and Prospect (2013-2023)
1.4.4 South America (Brazil, Argentina, Colombia) Molecular Blood Status and Prospect (2013-2023)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Molecular Blood Status and Prospect (2013-2023)
1.5 Global Market Size of Molecular Blood (2013-2023)
2 Manufacturers Profiles
2.1 Abbott Laboratories
2.1.1 Business Overview
2.1.2 Molecular Blood Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Abbott Laboratories Molecular Blood Revenue, Gross Margin and Market Share (2016-2017)
2.2 QIAGEN
2.2.1 Business Overview
2.2.2 Molecular Blood Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 QIAGEN Molecular Blood Revenue, Gross Margin and Market Share (2016-2017)
2.3 Roche Diagnostics
2.3.1 Business Overview
2.3.2 Molecular Blood Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Roche Diagnostics Molecular Blood Revenue, Gross Margin and Market Share (2016-2017)
2.4 Hologic
2.4.1 Business Overview
2.4.2 Molecular Blood Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Hologic Molecular Blood Revenue, Gross Margin and Market Share (2016-2017)
2.5 Grifols
2.5.1 Business Overview
2.5.2 Molecular Blood Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Grifols Molecular Blood Revenue, Gross Margin and Market Share (2016-2017)
2.6 Siemens Healthcare
2.6.1 Business Overview
2.6.2 Molecular Blood Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Siemens Healthcare Molecular Blood Revenue, Gross Margin and Market Share (2016-2017)
2.7 Becton, Dickinson
2.7.1 Business Overview
2.7.2 Molecular Blood Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Becton, Dickinson Molecular Blood Revenue, Gross Margin and Market Share (2016-2017)
2.8 Danaher
2.8.1 Business Overview
2.8.2 Molecular Blood Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Danaher Molecular Blood Revenue, Gross Margin and Market Share (2016-2017)
2.9 Biomerieux
2.9.1 Business Overview
2.9.2 Molecular Blood Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Biomerieux Molecular Blood Revenue, Gross Margin and Market Share (2016-2017)
2.10 Cepheid
2.10.1 Business Overview
2.10.2 Molecular Blood Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Cepheid Molecular Blood Revenue, Gross Margin and Market Share (2016-2017)
3 Global Molecular Blood Market Competition, by Players
3.1 Global Molecular Blood Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
3.2.1 Top 5 Molecular Blood Players Market Share
3.2.2 Top 10 Molecular Blood Players Market Share
3.3 Market Competition Trend
4 Global Molecular Blood Market Size by Regions
4.1 Global Molecular Blood Revenue and Market Share by Regions
4.2 North America Molecular Blood Revenue and Growth Rate (2013-2018)
4.3 Europe Molecular Blood Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Molecular Blood Revenue and Growth Rate (2013-2018)
4.5 South America Molecular Blood Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Molecular Blood Revenue and Growth Rate (2013-2018)
5 North America Molecular Blood Revenue by Countries
5.1 North America Molecular Blood Revenue by Countries (2013-2018)
5.2 USA Molecular Blood Revenue and Growth Rate (2013-2018)
5.3 Canada Molecular Blood Revenue and Growth Rate (2013-2018)
5.4 Mexico Molecular Blood Revenue and Growth Rate (2013-2018)
6 Europe Molecular Blood Revenue by Countries
6.1 Europe Molecular Blood Revenue by Countries (2013-2018)
6.2 Germany Molecular Blood Revenue and Growth Rate (2013-2018)
6.3 UK Molecular Blood Revenue and Growth Rate (2013-2018)
6.4 France Molecular Blood Revenue and Growth Rate (2013-2018)
6.5 Russia Molecular Blood Revenue and Growth Rate (2013-2018)
6.6 Italy Molecular Blood Revenue and Growth Rate (2013-2018)
7 Asia-Pacific Molecular Blood Revenue by Countries
7.1 Asia-Pacific Molecular Blood Revenue by Countries (2013-2018)
7.2 China Molecular Blood Revenue and Growth Rate (2013-2018)
7.3 Japan Molecular Blood Revenue and Growth Rate (2013-2018)
7.4 Korea Molecular Blood Revenue and Growth Rate (2013-2018)
7.5 India Molecular Blood Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Molecular Blood Revenue and Growth Rate (2013-2018)
8 South America Molecular Blood Revenue by Countries
8.1 South America Molecular Blood Revenue by Countries (2013-2018)
8.2 Brazil Molecular Blood Revenue and Growth Rate (2013-2018)
8.3 Argentina Molecular Blood Revenue and Growth Rate (2013-2018)
8.4 Colombia Molecular Blood Revenue and Growth Rate (2013-2018)
9 Middle East and Africa Revenue Molecular Blood by Countries
9.1 Middle East and Africa Molecular Blood Revenue by Countries (2013-2018)
9.2 Saudi Arabia Molecular Blood Revenue and Growth Rate (2013-2018)
9.3 UAE Molecular Blood Revenue and Growth Rate (2013-2018)
9.4 Egypt Molecular Blood Revenue and Growth Rate (2013-2018)
9.5 Nigeria Molecular Blood Revenue and Growth Rate (2013-2018)
9.6 South Africa Molecular Blood Revenue and Growth Rate (2013-2018)
10 Global Molecular Blood Market Segment by Type
10.1 Global Molecular Blood Revenue and Market Share by Type (2013-2018)
10.2 Global Molecular Blood Market Forecast by Type (2018-2023)
10.3 PCR Revenue Growth Rate (2013-2023)
10.4 PCR-RFLP Revenue Growth Rate (2013-2023)
10.5 AS-PCR or PCR-SSP Revenue Growth Rate (2013-2023)
10.6 Multiplex PCR Revenue Growth Rate (2013-2023)
10.7 Real Time PCR Revenue Growth Rate (2013-2023)
10.8 Sanger DNA Sequencing Revenue Growth Rate (2013-2023)
10.9 Pyrosequencing Revenue Growth Rate (2013-2023)
11 Global Molecular Blood Market Segment by Application
11.1 Global Molecular Blood Revenue Market Share by Application (2013-2018)
11.2 Molecular Blood Market Forecast by Application (2018-2023)
11.3 Blood Centers Revenue Growth (2013-2018)
11.4 Plasma Fractionation Facilities Revenue Growth (2013-2018)
11.5 Hospitals Revenue Growth (2013-2018)
11.6 Commercial/Private Laboratories Revenue Growth (2013-2018)
11.7 Military Blood Banks Revenue Growth (2013-2018)
12 Global Molecular Blood Market Size Forecast (2018-2023)
12.1 Global Molecular Blood Market Size Forecast (2018-2023)
12.2 Global Molecular Blood Market Forecast by Regions (2018-2023)
12.3 North America Molecular Blood Revenue Market Forecast (2018-2023)
12.4 Europe Molecular Blood Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Molecular Blood Revenue Market Forecast (2018-2023)
12.6 South America Molecular Blood Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Molecular Blood Revenue Market Forecast (2018-2023)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
List of Tables and Figures
Figure Molecular Blood Picture
Table Product Specifications of Molecular Blood
Table Global Molecular Blood and Revenue (Million USD) Market Split by Product Type
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
